Neurocare group AG Acquires Smart TMS Clinics in the UK

Munich, Germany, and London, UK - July 22, 2024 - neurocare group AG, a leader in personalized mental health care, has announced the acquisition of Smart TMS, the UK's largest provider of transcranial magnetic stimulation (TMS) treatment. Smart TMS operates nine clinics across the UK and Ireland. This acquisition expands neurocare's clinic network and introduces their Digital Therapy Platform (DTP) for more personalized therapy.

Norman Erhard, Senior Vice President Europe at neurocare group, expressed enthusiasm about the partnership. By integrating tools such as sleep assessment, psychotherapy, neurofeedback, and neuromodulation technologies like TMS, neurocare aims to enhance mental healthcare individualization. Founded in 2015, Smart TMS was a pioneer in using TMS for treating conditions like OCD, addiction, and adolescent psychiatry in the UK.

Dr. Leigh A. Neal, founder of Smart TMS, looks forward to leveraging neurocare's global network and resources to improve the deliverability of innovative mental health treatments across the UK. TMS, a non-invasive and medication-free treatment option, has demonstrated significant efficacy in treating various psychological disorders with minimal side effects.